[HTML][HTML] Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway
KF Hua, AC Chao, TY Lin, WT Chen, YC Lee… - Journal of Ginseng …, 2022 - Elsevier
Background Huntington's disease (HD) is a neurodegenerative disorder caused by the
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
[PDF][PDF] Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway
KF Hua, AC Chao, TY Lin, WT Chen, YC Lee, WH Hsu… - 2021 - researchgate.net
abstract Background: Huntington's disease (HD) is a neurodegenerative disorder caused by
the expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major …
the expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major …
Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway
KF Hua, AC Chao, TY Lin, WT Chen… - Journal of Ginseng …, 2022 - scholar.nycu.edu.tw
Background: Huntington's disease (HD) is a neurodegenerative disorder caused by the
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway.
KF Hua, AC Chao, TY Lin, WT Chen, YC Lee, WH Hsu… - 2022 - cabidigitallibrary.org
Background: Huntington's disease (HD) is a neurodegenerative disorder caused by the
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway.
KF Hua, AC Chao, TY Lin, WT Chen… - Journal of Ginseng …, 2021 - europepmc.org
Background Huntington's disease (HD) is a neurodegenerative disorder caused by the
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
[HTML][HTML] Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway
KF Hua, AC Chao, TY Lin, WT Chen… - Journal of Ginseng …, 2022 - ncbi.nlm.nih.gov
Background Huntington's disease (HD) is a neurodegenerative disorder caused by the
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway
KF Hua, AC Chao, TY Lin, WT Chen… - Journal of ginseng …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Huntington's disease (HD) is a neurodegenerative disorder caused by the
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
Ginsenoside compound K reduces the progression of Huntington\s disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway
KF Hua, AC Chao, TY Lin, WT Chen, YC Lee… - Journal of Ginseng …, 2022 - dbpia.co.kr
Background: Huntington" s disease (HD) is a neurodegenerative disorder caused by the
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …